CD276 and cancer: Cancer cell B7-H3 expression was more frequently observed in ampullary cancer patients (42 of 83 patients (51%), versus 21% of pancreatic cancer patients; p< 0,001), with 1 of these patients even showing strong B7-H3 expression in tumor cells.